Enduring challenge in the treatment of non small cell lung cancer with clinical stage IIIB: results of a trimodality approach

Medicine and Dentistry

• Patient 100%
• Surgery 71%
• Diseases 42%
• Non Small Cell Lung Cancer 42%
• Combination Therapy 28%
• Radiation Therapy 28%
• Clinical Stage 28%
• Complication 14%
• Chemotherapy 14%
• Morbidity 14%
• Age 14%
• Toxicity 14%
• Progressive Disease 14%
• Radical Resection 14%
• Pneumonectomy 14%
• Lobectomy 14%
• Intravenous Drug Administration 14%
• Cisplatin 14%
• Fluorouracil 14%
• Treatment of Non-Small Cell Lung Cancer 14%
• Malignant Pleural Effusion 14%
• Therapeutic Procedure 14%
• Death 14%
• Man 14%
• Inpatient 14%
• Survival 14%
• Woman 14%